Outcomes following intravitreal bevacizumab for aggressive posteriorly located retinopathy of prematurity at a tertiary institution.
dc.contributor.advisor | Visser, Linda. | |
dc.contributor.author | Jordaan, Thomas Johannes. | |
dc.date.accessioned | 2018-12-19T08:31:14Z | |
dc.date.available | 2018-12-19T08:31:14Z | |
dc.date.created | 2016 | |
dc.date.issued | 2016 | |
dc.description | Master of Medical Science in Ophthalmology. University of KwaZulu-Natal. Durban, 2017. | en_US |
dc.description.abstract | Abstract available in PDF file. | en_US |
dc.identifier.uri | http://hdl.handle.net/10413/15995 | |
dc.language.iso | en_ZA | en_US |
dc.subject.other | Aggressive posterior retimopathy of prematurity. | en_US |
dc.subject.other | Pathogenesis of retinopathy of prematurity. | en_US |
dc.subject.other | Cryotheraphy. | en_US |
dc.subject.other | Vitrectomy. | en_US |
dc.subject.other | Cenvententional laser therapy. | en_US |
dc.title | Outcomes following intravitreal bevacizumab for aggressive posteriorly located retinopathy of prematurity at a tertiary institution. | en_US |
dc.type | Thesis | en_US |